Skip to main content
    C

    Calumet Specialty Products Partners (CLMT)

    Official site

    BASIC MATERIALS • SPECIALTY CHEMICALS • NASDAQ

    $31.96
    -2.34 (-6.82%)

    Market Cap: $3.02B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Calumet Specialty Products Partners (CLMT) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Calumet Specialty Products Partners (CLMT) to earn $0.68 per share in the fiscal year ending Dec 31, 2026, on revenue of $5.28B. Of 6 analysts, 2 rate the stock Buy or Strong Buy, 4 Hold and 0 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 0 down.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 6 ratings average 2.67, inside the Hold band from 2.5 up to 3.5. Buy and Strong Buy make up 33% of the ratings.

    RatingAnalystsShare
    Strong Buy00.0%
    Buy233.3%
    Hold466.7%
    Sell00.0%
    Strong Sell00.0%
    Consensus
    Hold
    Total analysts
    6

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus rises 489.7% and revenue estimates fall 6.3%.

    Fiscal year ending Dec 31, 2026
    $0.68
    EPS consensus, revenue $5.28B
    Fiscal year ending Dec 31, 2027
    $4.01
    EPS consensus, revenue $4.95B
    Next report
    Feb 25, 2027
    Estimated

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$0.68-$1.27 to $1.693$5.28B$5.07B to $5.49B4
    Dec 31, 2027$4.01$4.01 to $4.011$4.95B$4.16B to $5.51B6

    Quarterly Estimates

    The EPS consensus rises from $0.88 for the quarter ending Dec 31, 2026 to $1.16 for the quarter ending Mar 31, 2027.

    EPS range

    Revenue range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$0.88$0.59 to $1.338$1.17B$892.29M to $1.39B8
    Mar 31, 2027$1.16$1.16 to $1.161$1.27B$1.04B to $1.41B3

    Estimate Revisions

    Across the 3 periods below, the last 30 days brought 3 upward and 0 downward EPS revisions. Raises outnumber cuts in every period.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202610
    Fiscal year ending Dec 31, 202710
    Quarter ending Mar 31, 202710

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 54.5% from $0.44.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026$0.68$0.70$0.16$0.16$0.44+54.8%
    Fiscal year ending Dec 31, 2027$4.01$3.20$0.63$0.63$0.63+536.5%
    Quarter ending Mar 31, 2027$1.16$0.88-$0.03-$0.03-$0.03N/A

    Frequently Asked Questions About CLMT

    What is the CLMT stock forecast?

    Consensus analyst estimates put Calumet Specialty Products Partners's EPS at $0.68 for the fiscal year ending Dec 31, 2026, on revenue of $5.28B. The consensus rating from 6 analysts is Hold.

    How do analysts rate CLMT stock?

    Of 6 analysts covering Calumet Specialty Products Partners, 0 rate it Strong Buy, 2 Buy, 4 Hold, 0 Sell and 0 Strong Sell, for a consensus of Hold.

    What EPS do analysts expect from CLMT next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $0.68, with estimates from -$1.27 to $1.69 from 3 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $4.01, with estimates from $4.01 to $4.01 from 1 analyst.

    What revenue do analysts expect from Calumet Specialty Products Partners next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $5.28B, with estimates from $5.07B to $5.49B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $4.95B, with estimates from $4.16B to $5.51B.

    How many analysts cover CLMT?

    6 analysts rate Calumet Specialty Products Partners stock, and 3 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.